These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 8607187

  • 1. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J, Lehmann M, Graser E, Hancock WW, Watschinger B, Onodera K, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 15; 61(5):804-11. PubMed ID: 8607187
    [Abstract] [Full Text] [Related]

  • 2. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 3. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
    Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW.
    J Immunol; 1997 Feb 15; 158(4):1572-81. PubMed ID: 9029092
    [Abstract] [Full Text] [Related]

  • 4. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T, Lehmann M, Flye MW.
    Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332
    [Abstract] [Full Text] [Related]

  • 5. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB.
    Transplantation; 1993 May 27; 55(5):1112-8. PubMed ID: 8497891
    [Abstract] [Full Text] [Related]

  • 6. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G, Hancock WW, Wasowska B, Badger AM, Kupiec-Weglinski JW.
    Transplantation; 1994 Mar 27; 57(6):933-41. PubMed ID: 8154043
    [Abstract] [Full Text] [Related]

  • 7. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
    Heidecke CD, Hancock WW, Westerholt S, Sewczik T, Jakobs F, Zantl N, Varzaru A, Siegling A, Kurrle R, Deusch K, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1996 Mar 27; 61(6):948-56. PubMed ID: 8623165
    [Abstract] [Full Text] [Related]

  • 8. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1999 Jul 27; 68(2):288-93. PubMed ID: 10440403
    [Abstract] [Full Text] [Related]

  • 9. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1996 Sep 01; 157(5):1944-50. PubMed ID: 8757313
    [Abstract] [Full Text] [Related]

  • 10. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ, Hancock WW, Schmidbauer G, Corpier CL, Wieder I, Kobzik L, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1993 Jul 15; 151(2):1158-66. PubMed ID: 8335897
    [Abstract] [Full Text] [Related]

  • 11. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B, Wieder KJ, Hancock WW, Zheng XX, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1996 Jan 01; 156(1):395-404. PubMed ID: 8598490
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M, Graser E, Risch K, Hancock WW, Müller A, Kuttler B, Hahn HJ, Kupiec-Weglinski JW, Brock J, Volk HD.
    Transplantation; 1997 Oct 27; 64(8):1181-7. PubMed ID: 9355837
    [Abstract] [Full Text] [Related]

  • 13. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW, Sayegh MH, Sablinski T, Kut JP, Kupiec-Weglinski JW, Milford EL.
    Transplantation; 1992 Jun 27; 53(6):1276-80. PubMed ID: 1604485
    [Abstract] [Full Text] [Related]

  • 14. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
    Heidecke CD, Zantl N, Maier S, Sewczik T, Westerholt S, Jakobs F, Westerholt A, Hancock WW, Kupiec-Weglinski JW.
    Transplantation; 1998 Nov 27; 66(10):1354-61. PubMed ID: 9846522
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW.
    Transplantation; 1995 Feb 27; 59(4):559-65. PubMed ID: 7878761
    [Abstract] [Full Text] [Related]

  • 16. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K, Arima T, Yu S, Lehmann M, Flye MW.
    Transplantation; 2000 Jan 27; 69(2):285-93. PubMed ID: 10670640
    [Abstract] [Full Text] [Related]

  • 17. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH, Schaub M, Magee CC, Kupiec-Weglinski JW, Sayegh MH.
    J Heart Lung Transplant; 2000 Jun 27; 19(6):566-75. PubMed ID: 10867337
    [Abstract] [Full Text] [Related]

  • 18. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.
    Lorant T, Krook H, Wilton J, Olausson M, Tufveson G, Korsgren O, Johnsson C.
    Xenotransplantation; 2003 Jul 27; 10(4):311-24. PubMed ID: 12795680
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
    Binder J, Graser E, Hancock WW, Wasowska B, Sayegh MH, Volk HD, Kupiec-Weglinski JW.
    Transplantation; 1995 Dec 27; 60(12):1516-24. PubMed ID: 8545884
    [Abstract] [Full Text] [Related]

  • 20. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
    Jaques BC, Ahmiedat H, Alastair Gracie J, Marshall HE, Middleton SE, Bolton EM, Bradley JA.
    Transplantation; 1998 Nov 27; 66(10):1291-9. PubMed ID: 9846511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.